Mission

Our mission is to improve health and healthcare for people, physicians and practices through the adoption of innovative products, technologies and services.

Vision

The AttoCaribbean Vision is to become the leading catalyst for clinical business success in the Caribbean & Latin America through the identification, distribution and widespread adoption of innovative, disruptive and differentiating medical technologies, products and services, leading to improved health and healthcare for people and improved clinical effectiveness and competitiveness for physicians and practices.

why do we exist

This can be explained by literally two short questions.

  • Why do new technology manufacturers (and existing) ignore a market greater in size than a major European country?
  • Why are our region’s physicians sometimes slow to adopt new technologies when in fact their success is dependent on being competitive and up-to-date?

It was my (Andrew Vincent, Founder) observation of these seemingly inexplicable conundrums and subsequent diagnosis that led to some enabling conclusions. Firstly, that for entrepreneurs and innovators, it is easy to overlook a valuable and accessible market in your focus on preparing yourself for major regional markets (US, Europe etc), missing out on early sales and proof of concept in a region just itching to find novel solutions to unique problems. Secondly, for physicians and practices, it is tough to keep up with the needs of running a successful practice alongside the trends in medical technology and innovation. It simply makes technology adoption feel like a gamble when in fact the right choices lead to competitive and clinical advantage.

Ironically, both problems have a common answer – AttoCaribbean. It’s a company devoted to identifying and following promising innovations in this sector and then removing the barriers for physician, practice and innovator for adoption. It sure does help that the team runs a healthcare practice, and were founders of an especially successful practice that made great use of new, advanced technologies and innovations.

core team

Mr Andrew Vincent

MBA DipM

Founder, Chief of Business & Strategy

30+ years’ experience in international strategic & operational healthcare marketing, strategy and business development. Successful history of establishing MedTech distribution in latest technologies. Joint Founder of Integra Healthcare Ltd, responsible for business strategy and marketing, leading it to become the largest non-hospital provider in Cayman Islands.

Dr Sara Watkin

MB ChB, MRCP (paeds), FRCPCH, MD

Medical Director & Clinical Specialist

30+ years’ experience as Consultant Paediatrician & Neonatologist. Joint Founder and former Medical Director and Clinical Lead for Paediatrics & Women’s Health, Integra Healthcare Ltd. Former Chief of Service NICU at University College London Hospitals. Former Clinical Reference Group Advisor to NHS England. Former Associate Responsible Officer for UCLH NHS Foundation Trust. Currently Consultant Paediatrician & Neonatologist and Medical Director, Optimal Healthcare Ltd.

Professor Andrew Shaw

Chief Scientist

Professor of Physical Chemistry and Astrochemistry. Academic Entrepreneur. Cambridge & Stanford trained. 20+ years Board experience. Multi-million-pound research in Industry and in Academia. First spin-out company, EvanesCo Ltd (counter terrorism), sold in 2006 for $8m. Founder & Chief Scientist of multi-award-winning Attomarker Ltd, diagnostic spin-out from Exeter University, now commercial stage.

core services

For Physicians and Clinics

We identify, follow, check the science on and liaise with the innovators and manufacturers of new products, technology and IT, with a view to evaluating its potential for improving care and/or competitiveness in the clinical arena. We do what you would struggle to have the time and budget to do properly.

For Innovators, Entrepreneurs & Manufacturers

We provide you with access to valuable, early adopting markets for your products and technologies that address the real world challenges facing Caribbean and Latin American countries, populations and health systems. Our unique context, including many being smaller Island nations or developing systems, leaves us as hungry for right solutions as you are for early sales and concept proof.

Enabling Fundraising Activity

We’re based in the Cayman Islands, home to a growing number of tech-focused or interested funds, family offices and investment channels. Additionally, we can introduce you to the tech and medical ecosystem focused on growing this sector in the region.

our story, simply put

AttoCaribbean Ltd is not an island. As a team, we are first and foremost healthcare professionals. We have a long history in healthcare technology and clinical practice. Since 2016, we find ourselves in the Cayman Islands, a unique and wonderful environment where the value is in the combination of experiences, not any single one.

Andrew Vincent carries 30+ years of experience in pharma, biotech, and medical devices, especially diagnostics and innovation-based technologies.
Sara Watkin is a tertiary paediatrician and neonatologist with a career history encompassing advising NHS England as part of a Clinical Reference Group on how to structure services and adopt best practise.

We moved here in 2016 and not long after started a clinical practice designed to be successful by raising the bar using latest practise, products and technologies, from its adoption of a latest generation electronic patient record to the acquisition of latest generation diagnostic technologies across a variety of specialties.

Having used the combination of these interests and this expertise to create the fastest growing and largest non-hospital clinical practice, it was time for the next chapter. That chapter involves AttoCaribbean Ltd for reasons already explained, and Optimal Healthcare Ltd, a new practice with a different but innovative and modern focus. That gives us an utterly unique ability to evaluate new technologies for their application and examine them from a clinical perspective. And as we have enough to do clinically here in Cayman, we set about creating a clinical network of like-minded practices across the region that could benefit from the work we are doing already.

And so here we are.

caribbean and central america

We thought you might be interested in some intriguing insights…
N

Population of Caribbean and Latin America is 669,397,546 (May 2024)

N

Population of Caribbean is 44,847,260

N

Population of Central America is 182,016,608

N

GDP per Capita Cayman Islands 99,624.89 USD (2022) versus United Kingdom 46,125.26 USD (2022)

N

Percentage of Healthcare Spend Privately in Caribbean and Latin America is 32.4% versus OECD average of 20%

N

Cause of Death in Caribbean and Latin America was 77% from Non-communicable Disease, with Cardiovascular Disease being most common

If we need to draw a conclusion, it’s that the region is a hotbed of unmet clinical and healthcare business need, with growing expenditure, rapidly growing expat populations and longstanding non-communicable healthcare challenges across both local and expat populations. Who wouldn’t want to help address that? We do!